GHRP-2

GHRP-2 (also known as Pramorelin) is a synthetic growth hormone secretagogue known to bind to the ghrelin/ghrelin/ghrelin receptor. It was the first growth hormone secretagogue to be introduced and is currently marketed as a test peptide for the assessment of growth hormone deficiency and secondary adrenal failure. GHRP-2 has been studied in Phase I clinical trials to assess short stature and is actively being studied for its effects on appetite, muscle growth, immune system, and sleep cycles. GHRP-2 is orally and sublingually active, so it works without the need for injections.